Hi @jkupratis, as you likely already know, the Food and Drug Administration (FDA) recently approved dupilumab (Dupixent) for treatment of adults and children 12 years and older with eosinophilic esophagitis. Dupilumab is a type of medicine known as a monoclonal antibody. It works to block the action of certain proteins in the body that cause inflammation. Dupilumab is given weekly via injection.

You'll find other members talking about this medication for the treatment of asthma and allergies in this related discussion:
- Anyone using Dupixent for asthma/allergy treatment?
https://connect.mayoclinic.org/discussion/asthma-and-dupixent/
When do you start treatment?